Edwards Lifesciences | EW - Beneficio Operativo

Precio De Mercado
81.10
Cambio Diario
-0.09 -0.11%
Mensual
-3.75%
Anual
20.92%
Q2 Expectativa
78.61




Beneficio Operativo Cambio Fecha
Abbott USD 2.25B 73M 2025-12
Artivion USD 4.79M 6.85M 2025-12
AtriCure USD 2.49M 2.28M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Boston Scientific USD 1.24B 203M 2025-12
Cooper Companies USD 212.8M 72.4M 2025-12
Dexcom USD 323M 80.5M 2025-12
Edwards Lifesciences USD 370.3M 54.8M 2025-12
Globus Medical USD 181.31M 298.83M 2025-12
Hologic USD 237M 16M 2025-12
ICU Medical USD 26.09M 770K 2025-12
Inogen USD -7.79M 728K 2024-09
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
Intuitive Surgical USD 865.3M 97.5M 2025-12
J&J USD 5.59B 1.81B 2025-12
Masimo USD 83.9M 300K 2025-12
Medtronic USD 1.74B 40M 2025-12
Merit Medical Systems USD 54.2M 11.58M 2025-12
Stryker USD 1.97B 609M 2025-12
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 36.34M 445.24M 2025-12
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12